Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health-Syst Pharm. 2002;59(11):1067-1076.
2. Britt GC, McCance-Katz EF. A brief overview of the clinical pharmacology of "club drugs." Subst Use Misuse. 2005;40(9-10):1189-1201.
3. Rimsza ME, Moses KS. Substance abuse on the college campus. Pediatr Clin North Am. 2005;52(1):307-319.
4. Rome ES. It's a rave new world: rave culture and illicit drug use in the young. Cleve Clin J Med. 2001;68(6):541-550.
5. Jones CM, Clayton HB, Deputy NP, et al. Youth Risk Behavior Surveillance—United States, 2019. MMWR. 2020;69(Suppl-1):40-46.
6. American Addiction Centers. Ecstasy Statistics and History. Available athttps://drugabuse.com/drugs/ecstasy/history-statistics. Last accessed November 22, 2024.
7. Monitoring the Future. Marijuana Use is Rising; Ecstasy Use is Beginning to Rise; and Alcohol Use is Declining Among U.S. Teens. Available athttps://monitoringthefuture.org/wp-content/uploads/2021/02/10drugpr_complete.pdf. Last accessed November 25, 2024.
9. Greene JP, Ahrendt D, Stafford EM. Adolescent abuse of other drugs. Adolesc Med Clin. 2006;17(2):283-318.
10. Substance Abuse and Mental Health Services Administration. The DAWN Report: Ecstasy-Related Emergency Department Visits by Young People Increased Between 2005 and 2011; Alcohol Involvement Remains a Concern. Available athttps://www.samhsa.gov/data/sites/default/files/spot127-youth-ecstasy-2013/spot127-youth-ecstasy-2013.pdf. Last accessed November 22, 2024.
11. United Nations Office on Drugs and Crime. World Drug Report 2024. Available athttps://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2024.html. Last accessed November 22, 2024.
13. National Institute on Drug Abuse. MDMA (Ecstasy/Molly). Available athttps://nida.nih.gov/research-topics/mdma-ecstasy-molly. Last accessed November 21, 2024.
14. National Drug Intelligence Center, Drug Enforcement Administration, United States Customs Service. Joint Assessment of MDMA Trafficking Trends. Johnstown, PA: National Drug Intelligence Center; 2000.
15. Sacco LN, Finklea K. Synthetic Drugs: Overview and Issues for Congress. Available athttps://sgp.fas.org/crs/misc/R42066.pdf. Last accessed November 25, 2024.
16. Baumeister D, Tojo LM, Tracy DK. Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol. 2015;5(2):97-132.
18. LexiDrug. Available athttps://online.lexi.com. Last accessed November 25, 2024.
19. 19. Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med. 2009;6(4):1072-1080.
20. Hahn I-H. MDMA Toxicity. Available athttps://emedicine.medscape.com/article/821572-overview. Last accessed November 25, 2024.
21. Andresen H, Aydin BE, Mueller A, Iwersen-Bergmann S. An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results. Drug Test Anal. 2011;3(9):560-568.
22. U.S. Drug Enforcement Administration. Drug Fact Sheet: GHB. Available athttps://www.dea.gov/sites/default/files/2020-06/GHB-2020_0.pdf. Last accessed November 25, 2024.
23. Drasbek KR, Christensen J, Jensen K. Gamma-hydroxybutyrate-a drug of abuse. Acta Neurol Scand. 2006;114(3):145-156.
24. Pardi D, Black J. Gamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs. 2006;20(12):993-1018.
25. 25. Benzer TI. Gamma-Hydroxybutyrate Toxicity. Available athttps://emedicine.medscape.com/article/820531-overview. Last accessed November 25, 2024.
26. van Noorden MS, Kamal R, de Jong CA, Vergouwen AC, Zitman FG. Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment. Ned Tijdschr Geneeskd. 2010;154:A1286.
27. Kamal RM, Schellekens A, De Jong Ca, Dijkstra BA. Baclofen as relapse prevention in the treatment of Gamma-Hydroxybutyrate (GHB) dependence: an open label study. BMC Psychiatry. 2015;15:91.
28. Li JH, Vicknasingam B, Cheung YW, et al. To use or not to use: an update on licit and illicit ketamine use. Subst Abuse Rehabil. 2011;2:11-20.
29. Rega PP. Hallucinogen Toxicity Treatment and Management. Treatment: Prehospital Care. Available athttps://emedicine.medscape.com/article/814848-treatment. Last accessed November 25, 2024.
30. U.S. Drug Enforcement Administration. DEA Drug Fact Sheet: Rohypnol. Available athttps://www.dea.gov/factsheets/rohypnol. Last accessed November 25, 2024.
31. U.S. Drug Enforcement Administration. Drugs of Abuse: A DEA Resource Guide, 2017 Edition. Available athttps://www.dea.gov/sites/default/files/drug_of_abuse.pdf. Last accessed November 25, 2024.
32. 32. Hall JA, Moore CBT. Drug-facilitated sexual assault: a review. J Forensic Leg Med. 2008;15(5):291-297.
33. Basheer C. Recent analytical strategies on "date-rape" drugs and its metabolites. J App Pharm Sci. 2011;1(6):21-28.
34. Brisset C, Leanza Y, Laforest K. Working with interpreters in health care: a systematic review and meta-ethnography of qualitative studies. Patient Educ Couns. 2013;91(2):131-140.
35. Hwa-Froelich DA, Westby CE. Considerations when working with interpreters. Commun Disord Q. 2003;24(2): 78-85.
36. Lynch EW. Developing cross-cultural competence. In: Lynch EW, Hanson MJ (eds). A Guide for Working with Children and Their Families: Developing Cross-Cultural Competence. 3rd ed. Baltimore, MD: Paul H. Brookes Publishing Co.; 2004.
38. U.S. Drug Enforcement Administration. Gamma Hydroxybutyric Acid. Available athttps://www.deadiversion.usdoj.gov/drug_chem_info/ghb.pdf. Last accessed November 25, 2024.
39. U.S. Drug Enforcement Administration. 2024 National Drug Threat Assessment (NDTA) Summary. Available athttps://www.dea.gov/sites/default/files/2024-05/5.23.2024%20NDTA-updated.pdf. Last accessed November 22, 2024.
40. Monitoring the Future. National Survey Results on Drug Use,1975--2023 Overview and Detailed Results for Secondary Students. Available athttps://monitoringthefuture.org/wp-content/uploads/2024/01/mtfoverview2024.pdf. Last accessed November 21, 2024.
41. U.S. Department of Health and Human Services. Trends in the Prevalence of Marijuana, Cocaine, and Other Illegal Drug Use National YRBS: 1991–2023. Available at https://yrbs-explorer.services.cdc.gov/#/graphs?questionCode=H54&topicCode=C03&location=XX&year=2023. Last accessed November 21, 2024.
42. UK Home Office. Circular 001/2022: Reclassification of GHB and related substances. Available athttps://www.gov.uk/government/publications/circular-0012022-reclassification-of-ghb-and-related-substances/circular-0012022-reclassification-of-ghb-and-related-substances. Last accessed November 22, 2024.
43. Substance Abuse and Mental Health Services Administration. 2023 National Survey on Drug Use and Health: Detailed Tables. Available at https://www.samhsa.gov/data/report/2023-nsduh-detailed-tables. Last accessed November 21, 2024.
44. Substance Abuse and Mental Health Services Administration. Findings from Drug-Related Emergency Department Visits, 2021. Available at https://store.samhsa.gov/sites/default/files/pep22-07-03-002.pdf. Last accessed November 21, 2024.
45. Lykos Theraputics. Lykos Therapeutics Announces Complete Response Letter for Midomafetamine Capsules for PTSD. Available at https://news.lykospbc.com/2024-08-09-Lykos-Therapeutics-Announces-Complete-Response-Letter-for-Midomafetamine-Capsules-for-PTSD. Last accessed November 22, 2024.
46. van Amsterdam JG, van Laar M, Brunt TM, van den Brink W. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. Regul Toxicol Pharmacol. 2012;63(1):55-63.
47. Hill A. Ketamine Statistics On Use and Abuse. Available at https://www.addictiongroup.org/resources/ketamine-statistics/. Last accessed November 22, 2024.
48. Karabatur D. The Ketamine Boom: How the Wealthy are Getting Their Hands on the In-Demand Drug. Available at https://www.latimes.com/california/newsletter/2024-05-30/the-ketamine-boom-how-the-wealthy-are-getting-their-hands-on-the-in-demand-drug-essential-california. Last accessed November 22, 2024.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.